FDA Warning Letter Urges St. Gobain To Get Hip To QSR Regs
This article was originally published in The Gray Sheet
Saint Gobain Advanced Ceramics Desmarquest did not adaquately verify and validate changes it made to its manufacturing process in 1998, FDA asserts in a recent warning letter outlining quality system reg (QSR) deficiencies related to certain artificial hip components
You may also be interested in...
Zimmer will pay non-reimbursed direct medical costs associated with revision surgery for patients who were implanted with certain recalled Saint Gobain Advanced Ceramic Desmarquest zirconia ceramic femoral heads distributed by the Warsaw, Indiana-based firm
The United Kingdom and Australia have issued device alert notices regarding the recall of Saint Gobain Advanced Ceramics Desmarquest zirconia ceramic femoral heads, following an Aug. 10 decision by the French government to suspend production and recall nine batches of the prosthetic hip components.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.